Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AG-881
Agios Netherlands B.V.
Healthy Participants
1 trial -
AG-881
Agios Netherlands B.V.
Healthy Male Participants
1 trial -
AG-946
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG120
Agios Netherlands B.V.
Healthy
2 trials -
AG221
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG881
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG881 Formulation 1
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AGMB-129
Agomab Therapeutics NV
Healthy Volunteers
2 trials -
AKB-6548
Akebia Europe Limited
Healthy Volunteers
1 trial -
AKB-6548 (therapeutic dose)
Akebia Europe Limited
Healthy Volunteers
1 trial -
AKB-6548-CI-0013
Akebia Europe Limited
Healthy
1 trial -
AKB-9090
Akebia Europe Limited
Healthy Volunteers
1 trial -
ALG-055009
Aligos Therapeutics
Healthy Volunteer Study
1 trial -
ALN-4285
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-4915
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-AGT01 RVR
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-ANG3
Regeneron UK Limited
Healthy Volunteers With Hyperlipidemia
1 trial -
ALN-F1202
Regeneron UK Limited
Healthy Volunteer
1 trial -
ALPN-101
CNS Pharmaceuticals
Healthy Volunteers
1 trial -
AMO-02-MD-1-001
Lacuna Pharma Pty Ltd
Hepatic impairment, Healthy subjects
1 trial -
AN2-502998
AN2 Therapeutics
Healthy Volunteers
1 trial -
ARAVA® 20 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
ARC-520
Arrowhead Pharmaceuticals Ireland Limited
Healthy
2 trials -
ARN-75039 oral capsules
United Therapeutics Europe Ltd
Healthy Adult Participants
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.